Tirzepatide: Best for maximum weight loss Why it's even more powerful: Dual GIP/GLP-1 agonist Clinical trials show 20-25% body weight loss Even stronger appetite suppression than semaglutide Better blood sugar control FDA-approved (Mounjaro for diabetes, Zepbound for weight loss) Best for: Maximum fat loss Stubborn obesity Pre-diabetic or diabetic When semaglutide doesn't work well enough Dosing: Start: 2.5mg weekly Titrate up to 5-15mg weekly Injectable subcutaneous once weekly More expensive than semaglutide Semaglutide vs Tirzepatide: Semaglutide: Proven, slightly cheaper, excellent results Tirzepatide: More powerful, better glucose control, highest weight loss Both work excellently See semaglutide vs tirzepatide , peptides for weight loss , best peptides for weight loss , and best peptide stack for weight loss
It also can stimulate and balance the immune system, guard against neurotoxicity, and prevent blood clots
2007 Oct-Dec;113(4-5):234-58
Key Leaders: Nathan Hubbard, CEO Number of Employees: More than 2,500 Stage: Acquired Financial Snapshot: Valued at $1.9 billion during acquisition Notable Investors: Roche, Google Ventures (GV), Allen & Company, Baillie Gifford, and Casdin Capital Key Product: Flatiron Health offers OncoEMR, an electronic medical record (EMR) system that helps medical teams manage patient data and treatment plans and streamline internal workflows